Pfizer-BioTech seek vaccine OK for children aged 12 to 15 - Android

Brussels, Apr 30: Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies'' coronavirus vaccine to include children ages 12 to 15, a move that could offer younger and less at-risk populations